Genital herpes is one of the most common venereal diseases in the United States. It is caused by herpes simplex virus (HSV), particularly HSV type 2 (HSV-2) (11). These infections can be primary or recurrent and pose a great risk to the neonate when a pregnant mother has active genital herpes at the time of delivery (5). If HSV infection is present at term, the delivery should be performed by cesarean section to reduce the risk of transmission of the virus to the newborn (5). The constraints of time and risk to the newborn emphasize the need for a sensitive and rapid test which can give reliable information about the presence of HSV.
Genital herpes is one of the most common venereal diseases in the United States. It is caused by herpes simplex virus (HSV), particularly HSV type 2 (HSV-2) (11). These infections can be primary or recurrent and pose a great risk to the neonate when a pregnant mother has active genital herpes at the time of delivery (5) . If HSV infection is present at term, the delivery should be performed by cesarean section to reduce the risk of transmission of the virus to the newborn (5) . The constraints of time and risk to the newborn emphasize the need for a sensitive and rapid test which can give reliable information about the presence of HSV.
Some of the methods currently available to detect HSV include conventional tissue culture techniques (15), shortterm tissue culture followed by staining (12, 13) or electron microscopy (9) , and direct staining of tissue smears taken from the lesions of the patient (3, 7, 17, 18) . The tissue culture method is generally considered standard, but it requires up to 7 days for completion. We have reported that short-term tissue culture followed by staining is as sensitive as and more rapid (24 h) than tissue culture alone (12, 13) . Direct staining of tissue smears is rapid, but not as sensitive or specific as tissue culture (13) , and electron microscopy is rapid, but less available and less sensitive than tissue culture (9) .
The objective of this study was to develop a more rapid, sensitive, specific technique to detect HSV without the use of tissue culture. The present report describes a method in which specific antibody was used to capture HSV antigen. This was then detected with a second antibody linked with biotin and streptavidin-enzyme conjugate in the immunosorbent assay.
(Parts of this work were presented at the Second Annual MATERIALS AND METHODS Preparation of stock virus. HSV-1 and -2 were grown in monolayer cultures of owl monkey kidney cells maintained on complete Eagle minimum essential medium (EMEM; Microbiological Associates, Bethesda, Md.) containing 2 mM glutamine (GIBCO Laboratories, Madison, Wis.), penicillin (100 U/ml), and streptomycin (100 jig/ml) with 2% fetal calf serum. The culture supernatants were harvested at 48 h and concentrated 10-fold with an Amicon fiberglass concentrator (Amicon Corp., Lexington, Mass.). The virus was further purified by discontinuous density gradient centrifugation with 20 and 60% sucrose in Tris buffer (20 mM; pH 7.8) with EDTA (1 mM) and NaCl (0.15 M). The virus was collected from the interphase of 20 and 60% sucrose and stored frozen in small portions at -70°C until used.
Collection of clinical specimens. Clinical specimens were collected from patients by rubbing lesions or genital areas or both with sterile cotton swabs. The swabs were transferred to 3 ml of Hanks balanced salt solution containing streptomycin, penicillin, acromycin, mycostatin, and gentamicin (henceforth referred to as collection medium), refrigerated before and during transport, and frozen at -70°C if not studied immediately (15 (iii) Preparation of streptavidin-enzyme conjugates. Streptavidin was obtained from Bethesda Research Laboratories, Inc., Gaithersburg, Md. Purified alkaline phosphatase prepared from bovine calf intestine was obtained from Sigma Chemical Co., St. Louis, Mo. The streptavidin-alkaline phosphatase conjugates were prepared by a one-step glutaraldehyde conjugation procedure as described previously (20) . During initial trials, egg avidin-enzyme conjugates (Vector) were compared with streptavidin-enzyme conjugates prepared by us. The streptavidin conjugates were found to be much superior to the egg avidin-enzyme conjugates and hence were used in all experiments described in this report.
(iv) Performance of capture B/SA ELISA. All tests were run against anti-HSV-1 and -2 antibody reagents simultaneously. The capture antibodies were identical to the detecting antibodies except that the latter were linked with biotin. The microtiter plates were coated with various concentrations of rabbit anti-HSV-1 and -2 immunoglobulin G preparations. An antibody dilution of 1:250 was found to be sufficient to capture the levels of viral antigen present in the clinical specimens. This dilution of antibody was used in all the subsequent experiments. Microtiter plates were sensitized with 300 RI of antibody diluted in sodium carbonatebicarbonate buffer (1.59 g of Na2CO3, 2.93 g of NaHCO3, 0.2 g of sodium azide per liter [pH 9.6]) in a humid chamber at 4°C overnight (20) . The plates were washed three times with phosphate-buffered saline containing 0.05% Tween 20 (Sigma), 0.1% bovine serum albumin (Miles Laboratories, Inc., Elkhart, Ind.), and 0.02% sodium azide (Sigma), henceforth referred to as ELISA wash. Stock virus or clinical specimens were then added at least in duplicate (100 ,ul per well), and the plates were incubated at 37°C in a 5% CO2 incubator. The optimum time of incubation was determined to be 2 h in the initial experiments. Unbound material was removed by washing the plates three times with ELISA wash. Pretitrated biotin-linked antibody diluted in phosphate-buffered saline containing 0.05% Tween 20, 1.0% bovine serum albumin, and 0.02% sodium azide (100 ,ul per well) was added to the plates. After incubation for 1 h at 37°C in a humid chamber, the plates were washed three times with ELISA wash. Pretitrated streptavidin-alkaline phosphatase conjugate (100 pul per well) was then added, followed by incubation for 0.5 h at 37°C in a humid chamber. The optimum time of incubation on the last two steps was evaluated in the initial experiments. The unbound conjugate was removed by washing thoroughly, and 100 p1 of substrate (para-nitrophenyl phos- The fluorogenic substrate methylumbelliferyl phosphate was evaluated in the assay (21) . It did not improve the sensitivity of detection of HSV antigen in clinical specimens or in purified virus preparations.
(v) Evaluation of results. The absorbance reading on at least duplicates of specimens and four to eight replicates of viral control medium were averaged, and standard deviation (SD) of the control average in a given experiment was calculated. The specimens which had an average absorbance value equal to or above the predicted limit of absorbance value for a positive were considered positive. The predicted limit of absorbance value for a positive was determined by using the 95% prediction bound formula T + (SDv Cf . 95% * V(n + 1)1n), where x and SD j are the average and the standard deviation, respectively, of n observations of control buffer absorbance values and Cf. 9S% is the t value at 95% probability forf (= n -1) degrees of freedom.
Inactivation of stock HSV. Inactivation of stock HSV in distilled water, in EMEM at 37°C, and in water containing hypochlorite was performed as previously described (14) . Inactivation by UV irradiation and by Triton X-100 (final concentration, 1%) was carried out for 3 min at room temperature.
Specificity of HSV detection. Specificity of the assay was tested with cytomegalovirus, Candida albicans, and Staphylococcus aureus. Since C. albicans and S. aureus are frequently seen in genital ihfections, mixing experiments were performed to determine whether they interfered with HSV detection. The clinical specimens which showed contaminations by tissue culture were also studied by the capture B/SA ELISA.
Inhibition of HSV antigen detection. The presence of HSV antigen in clinical specimens and stock virus preparations was confirmed by blocking the detection with rabbit and human HSV-1-and -2-specific antisera. Preimmune sera or sera without HSV-specific antibodies were used in the negative control. In these experiments, the specimens or stock virus preparations were allowed to react with antibody-coated plates for 2 h and were washed three times with ELISA wash. The unlabeled rabbit or human anti-HSV serum or their respective preimmune or negative control sera were then added, and the incubation was carried out for 1 h at 37°C in a humid atmosphere. The plates were washed three times with ELISA wash, and the remaining steps, e.g., from those involving a reaction with biotin-linked antibody to those showing the development of color in the alkaline phosphatase reaction, were followed as discussed above. This methodology ensured the capture of antigen but blocked only the detection. All the reactions were carried out in duplicate. The inhibition by either rabbit or human serum was considered positive when it was more than that achieved by the respective preimmune or negative sera.
RESULTS
The evaluation of various plastic microtiter plates for the capture B/SA ELISA is given in Table 1 . Costar and Immulon II polystyrene plates, which are UV irradiated, gave the best results when the complete HSV capture reaction was carried out with different amounts of purified HSV-1. Immulon II plates showed slightly but not significantly higher absorbance values. Polyvinyl chloride plates were rated between irradiated polystyrene plates and unirradiated Immulon I polystyrene plates. Immulon I plates were not acceptable because of suboptimal binding. All experiments described in this report were performed with Costar plates.
The optimum time of incubation for antigen capture was determined. The antigen binding was generally linear up to 2 h. Incubation beyond 2 h did not give a significant increase in absorbance readings and did not improve sensitivity of detection of virus but did increase the background readings. In all the experiments discussed in this report, 2 h of incubation was used with specimens.
The optimum time of incubation with the biotin-linked antibody and streptavidin-alkaline phosphatase conjugate was determined. The optimum time for the biotin-antibody step was 60 min, and that for the streptavidin-alkaline phosphatase conjugate step was 30 min. Again, longer incubation times did not add to the sensitivity of detection, but they increased absorbance readings for both antigen and control materials. The use of a fluorogenic substrate did not improve sensitivity of detection of HSV antigen in our assay, as has been reported elsewhere (21) . Table 2 indicates the sensitivity of detection of gradientpurified HSV-1 and -2 stock preparations by the capture B/SA ELISA. The method allowed detection of the virus at infectivity concentrations of 5 x 103 TCID50 per ml for HSV-1 (i.e., 500 TCID50 per 100 jil of sample) and 5 x 104 TCID50 per ml for HSV-2 (i.e., 5,000 TCID50 per 100 [l of sample).
Simultaneous use of HSV-1 and -2 reagents in the initial experiments showed greater sensitivity for detection of HSV in clinical specimens. To confirm that the capture B/SA ELISA was indeed detecting HSV antigens alone and not other proteins, several specimens were tested in the blocking experiments. The typing of HSV in these specimens was performed by restriction enzyme analysis (L. S. Nerurkar and N. Miller, personal communication) and by fluorescence staining (12) . The results of a representative experiment are given in Table 3 . Most of the specimens (9 of 12, as shown in Table 3 ) showed no inhibition by negative human serum and low-level inhibition (0 to 23%) with preimmune rabbit serum. The inhibition by positive sera ranged from 78 to 99% for hyperimmune rabbit serum, 46 to 77% for low-positive human serum, and 62 to 83% for high-positive human serum.
This confirmed that the capture B/SA ELISA detects HSV antigens.
For a comparison of the detection of HSV or HSV antigen in clinical specimens by tissue culture and by the capture B/ SA ELISA, 325 clinical specimens were studied by both techniques in 11 different experiments. With tissue culture technique as a standard the ELISA showed complete correlation of results, with 107 positive specimens (sensitivity, 95.6%) and 195 negative specimens (specificity, 91.4%). Five specimens were tissue culture positive and antigen negative. These five specimens required five to seven days to show the presence of virus, and only one of three to four replicate cultures showed cytopathic effects. This suggests that the virus concentration was very low in these specimens. The presence of HSV and viral antigens in the isolates prepared from these five specimens was confirmed by tissue culture on rabbit kidney cells and by the capture B/SA ELISA, respectively. There were 18 specimens which were tissue culture negative and antigen positive. Of these 18 specimens, 16 were further studied by inhibition assay with rabbit and human sera and were found to contain HSV antigens (Table   4 ). antigen value (absorbance at 405 nm). In general, specimens with higher infectivity titers showed higher absorbance values; however, there were a few specimens with low infectivity which showed evidence of considerable antigenicity. Thus, the infectivity and antigen level of the clinical specimens could not be well correlated. Table 5 compares the tissue culture and capture B/SA ELISA methods for detection of HSV in samples inactivated by different treatments. Infectious virus could not be detected after 24 h of incubation in distilled water or in EMEM at 37°C. In contrast, viral antigens could be detected by the capture B/A ELISA, though in small amounts, beyond 24 h, indicating that HSV antigen could be recognized after the viral infectivity was lost. UV irradiation or treatment of HSV specimens with Triton X-100 destroyed the virus infectivity completely or nearly completely but retained the '1. antigenicity were destroyed instantaneously. Table 6 shows results of experiments in which S. aiureius and C. albicans were added to stock HSV-1 and -2. It was clear that neither C. albic-ans nor S. alureius significantly affected the assay. Cytomegalovirus was not detected with these reagents. The culture-negative specimens did not show any false-positive reactions after the addition of S. aiurelus. Also, the contaminated specimens did not show any reaction in the capture B/SA ELISA. This further supported the specificity for HSV antigens of the assay described here.
DISCUSSION
The capture B/SA ELISA method had excellent sensitivity for the detection of HSV in clinical specimens. The method detected HSV antigen in 95.6% of clinical samples which were positive by conventional tissue culture methods. With purified virus, the method was less sensitive than was tissue culture. This is probably related to the smaller amounts of noninfectious viral antigens which are present in the purified samples (Table 2 and Fig. 2 ). The method also detected HSV in samples which were inactivated at 37°C or by UV irradiation or Triton X-100 treatments, when the infectious virus could no longer be detected. Capture ELISA methods have been reported for detection of several viruses (2, 4, 6, 8, 10, 19, 22) . The method reported previously for the detection of HSV antigens in genital specimens (19) was evaluated in our laboratory but was found to have low sensitivity. This method used antibody-enzyme direct conjugates as the detecting antibody, rather than the biotin-streptavidin system used in our studies. The advantage of the biotin-streptavidin system is that it has a very high binding constant (10'') . and this binding ability appears to increase the sensitivity of the test (1) . We have previously noted that genital specimens may have very low concentrations of virus (12) , and it appears that, unless the sensitivity of the assay is sufficiently high. the capture ELISA will not be able to detect this virus. Preliminary studies with egg avidin-enzyme conjugate showed lower sensitivity, and streptavidin was selected for all of the studies reported in this paper.
Several other methods for rapid detection of HSV have been reported. including direct immunofluorescence (17. 18), direct immunoperoxidase (17) , and Papanicolaou or crystal violet staining (3). These tests are direct, do not include tissue culture amplification of virus, and have lower sensitivity than does the tissue culture method. In our laboratory, for example, smears from HSV lesions stained by immunofluorescence with the biotin-avidin system detected the viral antigens with 89% sensitivity and 62% specificity compared with the tissue culture method (13) . The disadvantage of non-tissue culture, direct-detection methods, e.g., direct immunofluorescence of clinical smears, is that they require intact tissue or cells which show the presence of viral antigens or morphological change or both. These methods do not detect non-cell-associated virus. The ELISA antigen capture method does not have this disadvantage, since it allows detection of any antigenic material which is present in the sample. The ELISA also detects antigen in the absence of virus infectivity. In contrast, the tissue culture method is strictly based on the infectivity of the virus. The capture ELISA, however, will not detect the antigen when the antigenicity is destroyed by hypochlorite treatment and the antigen can no longer react with the antibody.
The specificity of the capture B/SA ELISA was 91.4%. The discrepant results involved 18 specimens which were negative by tissue culture. Blocking studies conducted with specific rabbit and human sera with the 16 specimens which were available showed interference by the appropriate sera and not by antibody-negative sera. The results suggest that these 16 specimens contained HSV antigen, and the specificity of the test was actually greater than 91.4%. The addition of S. alureus or C. albicans to stock HSV did not significantly influence the test results, and the contaminated specimens could be assayed satisfactorily. Also, the test was not positive with human cytomegalovirus, further demonstrating the specificity of this method for HSV antigens.
The capture B/SA ELISA could be performed in 4.5 h. This is considerably faster than tissue culture methods (15) and other reliable, comparably sensitive tests (12, 13 
